Drug Standards
- (2)
- (4)
- (1)
- (3)
- (3)
- (665)
- (3)
- (27)
- (1)
- (6)
- (27)
- (61)
- (24)
- (1)
- (2)
- (35)
- (367)
- (45)
- (1)
- (2)
- (1)
- (5)
- (5)
- (4)
- (2)
- (7)
- (1)
- (5)
- (4)
- (3)
- (3)
- (1)
- (3)
- (2)
- (2)
- (1)
- (2)
- (3)
- (4)
- (2)
- (2)
- (1)
- (1)
- (3)
- (1)
- (1)
- (1)
- (4)
- (1)
- (1)
- (1)
- (1)
- (4)
- (3)
- (1)
- (1)
- (2)
- (5)
- (1)
- (2)
- (4)
- (1)
- (1)
- (3)
- (5)
- (3)
- (1)
- (2)
- (1)
- (1)
- (1)
- (3)
- (1)
- (1)
- (3)
- (4)
- (2)
- (2)
- (1)
- (4)
- (4)
- (5)
- (3)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (3)
- (4)
- (3)
- (1)
- (4)
- (1)
- (2)
- (1)
- (5)
- (2)
- (2)
- (1)
- (5)
- (7)
- (3)
- (1)
- (1)
- (1)
- (4)
- (1)
- (3)
- (1)
- (4)
- (1)
- (8)
- (2)
- (1)
- (5)
- (13)
- (1)
- (2)
- (1)
- (1)
- (1)
- (2)
- (4)
- (1)
- (5)
- (1)
- (1)
- (2)
- (1)
- (6)
- (2)
- (1)
- (2)
- (2)
- (1)
- (3)
- (1)
- (2)
- (2)
- (1)
- (1)
- (3)
- (3)
- (1)
- (1)
- (2)
- (3)
- (1)
- (1)
- (1)
- (2)
- (4)
- (3)
- (1)
- (1)
- (5)
- (3)
- (2)
- (5)
- (1)
- (3)
- (1)
- (1)
- (1)
- (1)
- (1)
- (2)
- (1)
- (1)
- (1)
- (2)
- (2)
- (1)
- (2)
- (2)
- (4)
- (4)
- (1)
- (2)
- (2)
- (1)
- (2)
- (4)
- (5)
- (2)
- (1)
- (3)
- (2)
- (2)
- (11)
- (1)
- (2)
- (2)
- (2)
- (5)
- (5)
- (4)
- (2)
- (4)
- (2)
- (1)
- (2)
- (5)
- (2)
- (2)
- (1)
- (2)
- (3)
- (2)
- (2)
- (5)
- (3)
- (2)
- (2)
- (1)
- (4)
- (3)
- (1)
- (1)
- (2)
- (2)
- (3)
- (2)
- (2)
- (3)
- (2)
- (1)
- (1)
- (5)
- (1)
- (2)
- (5)
- (5)
- (2)
- (1)
- (1)
- (2)
- (2)
- (1)
- (1)
- (7)
- (2)
- (2)
- (1)
- (3)
- (1)
- (3)
- (2)
- (5)
- (2)
- (2)
- (2)
- (2)
- (5)
- (2)
- (1)
- (6)
- (3)
- (2)
- (1)
- (5)
- (5)
- (2)
- (2)
- (1)
- (6)
- (1)
- (1)
- (1)
- (1)
- (5)
- (1)
- (2)
- (4)
- (1)
- (3)
- (1)
- (1)
- (2)
- (1)
- (1)
- (2)
- (1)
- (1)
- (1)
- (1)
- (2)
- (1)
- (1)
- (2)
- (2)
- (1)
- (2)
- (1)
- (1)
- (5)
- (2)
- (2)
- (1)
- (1)
- (2)
- (8)
- (4)
- (14)
- (7)
- (8)
- (1)
- (3)
- (1)
- (6)
- (1)
- (1)
- (5)
- (2)
- (1)
- (1)
- (2)
- (20)
- (4)
- (5)
- (1)
- (3)
- (2)
- (1)
- (7)
- (8)
- (7)
- (2)
- (1)
- (2)
- (1)
- (3)
- (5)
- (5)
- (1)
- (3)
- (1)
- (3)
- (6)
- (3)
- (3)
- (1)
- (2)
- (26)
- (54)
- (5)
- (11)
- (4)
- (6)
- (6)
- (16)
- (1)
- (129)
- (3)
- (1)
- (2)
- (5)
- (4)
- (14)
- (38)
- (3)
- (13)
- (12)
- (7)
- (1)
- (6)
- (6)
- (6)
- (1)
- (1)
- (1)
- (1)
- (1)
- (12)
- (38)
- (5)
- (1)
- (2)
- (1)
- (1)
- (12)
- (2)
- (15)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (6)
- (15)
- (2)
- (1)
- (19)
- (3)
- (18)
- (1)
- (1)
- (1)
- (1)
- (2)
- (1)
- (29)
- (3)
- (2)
- (1)
- (2)
- (1)
- (1)
- (6)
- (1)
- (1)
- (1)
- (1)
- (44)
- (2)
- (27)
- (1)
- (73)
- (6)
- (73)
Filtered Search Results
Pioglitazone Hydrochloride 98.0+%, TCI America™
CAS: 112529-15-4 Molecular Formula: C19H21ClN2O3S Molecular Weight (g/mol): 392.898 MDL Number: MFCD04975446 InChI Key: GHUUBYQTCDQWRA-UHFFFAOYSA-N Synonym: 5-[4-[2-(5-Ethyl-2-pyridyl)ethoxy]benzyl]-2,4-thiazolidinedione Hydrochloride PubChem CID: 60560 IUPAC Name: 5-[[4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione;hydrochloride SMILES: CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3.Cl
| PubChem CID | 60560 |
|---|---|
| CAS | 112529-15-4 |
| Molecular Weight (g/mol) | 392.898 |
| MDL Number | MFCD04975446 |
| SMILES | CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3.Cl |
| Synonym | 5-[4-[2-(5-Ethyl-2-pyridyl)ethoxy]benzyl]-2,4-thiazolidinedione Hydrochloride |
| IUPAC Name | 5-[[4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione;hydrochloride |
| InChI Key | GHUUBYQTCDQWRA-UHFFFAOYSA-N |
| Molecular Formula | C19H21ClN2O3S |
Rosuvastatin Calcium 95.0+%, TCI America™
CAS: 147098-20-2 Molecular Formula: C44H60CaF2N6O12S2 Molecular Weight (g/mol): 1007.189 MDL Number: MFCD04112702 InChI Key: LQFSLFAVBQEFBH-LSMDDVBQSA-N PubChem CID: 131673834 IUPAC Name: calcium;(E,3R,5S)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid;molecular hydrogen SMILES: [HH].[HH].CC(C)C1=NC(=NC(=C1C=CC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C.CC(C)C1=NC(=NC(=C1C=CC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C.[Ca]
| PubChem CID | 131673834 |
|---|---|
| CAS | 147098-20-2 |
| Molecular Weight (g/mol) | 1007.189 |
| MDL Number | MFCD04112702 |
| SMILES | [HH].[HH].CC(C)C1=NC(=NC(=C1C=CC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C.CC(C)C1=NC(=NC(=C1C=CC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C.[Ca] |
| IUPAC Name | calcium;(E,3R,5S)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid;molecular hydrogen |
| InChI Key | LQFSLFAVBQEFBH-LSMDDVBQSA-N |
| Molecular Formula | C44H60CaF2N6O12S2 |
Sertraline Hydrochloride 98.0+%, TCI America™
CAS: 79559-97-0 Molecular Formula: C17H18Cl3N Molecular Weight (g/mol): 342.688 MDL Number: MFCD00895772 InChI Key: BLFQGGGGFNSJKA-XHXSRVRCSA-N Synonym: (1S,4S)-1-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-4-(methylamino)naphthalene Hydrochloride PubChem CID: 63009 ChEBI: CHEBI:9124 IUPAC Name: (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine;hydrochloride SMILES: CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl.Cl
| PubChem CID | 63009 |
|---|---|
| CAS | 79559-97-0 |
| Molecular Weight (g/mol) | 342.688 |
| ChEBI | CHEBI:9124 |
| MDL Number | MFCD00895772 |
| SMILES | CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl.Cl |
| Synonym | (1S,4S)-1-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-4-(methylamino)naphthalene Hydrochloride |
| IUPAC Name | (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine;hydrochloride |
| InChI Key | BLFQGGGGFNSJKA-XHXSRVRCSA-N |
| Molecular Formula | C17H18Cl3N |
Protamine Sulfate from Salmon sperm, TCI America™
CAS: 53597-25-4 MDL Number: MFCD00132091 Synonym: Salmine Sulfate
| CAS | 53597-25-4 |
|---|---|
| MDL Number | MFCD00132091 |
| Synonym | Salmine Sulfate |
Rhynchophylline 98.0+%, TCI America™
CAS: 76-66-4 Molecular Formula: C22H28N2O4 Molecular Weight (g/mol): 384.476 MDL Number: MFCD00221748 InChI Key: DAXYUDFNWXHGBE-GXONQVTISA-N PubChem CID: 102004527 IUPAC Name: methyl (E)-2-[(6'R,7'S,8'aS)-6'-ethyl-2-oxospiro[1H-indole-3,1'-3,5,6,7,8,8a-hexahydro-2H-indolizine]-7'-yl]-3-methoxyprop-2-enoate SMILES: CCC1CN2CCC3(C2CC1C(=COC)C(=O)OC)C4=CC=CC=C4NC3=O
| PubChem CID | 102004527 |
|---|---|
| CAS | 76-66-4 |
| Molecular Weight (g/mol) | 384.476 |
| MDL Number | MFCD00221748 |
| SMILES | CCC1CN2CCC3(C2CC1C(=COC)C(=O)OC)C4=CC=CC=C4NC3=O |
| IUPAC Name | methyl (E)-2-[(6'R,7'S,8'aS)-6'-ethyl-2-oxospiro[1H-indole-3,1'-3,5,6,7,8,8a-hexahydro-2H-indolizine]-7'-yl]-3-methoxyprop-2-enoate |
| InChI Key | DAXYUDFNWXHGBE-GXONQVTISA-N |
| Molecular Formula | C22H28N2O4 |
Enalapril Maleate 98.0+%, TCI America™
CAS: 76095-16-4 Molecular Formula: C24H32N2O9 Molecular Weight (g/mol): 492.53 MDL Number: MFCD00133304,MFCD00865774 InChI Key: OYFJQPXVCSSHAI-BMSLDGIRSA-N Synonym: enalapril maleate,renitec,glioten,vasotec,baripril,benalapril,crinoren,innovace,naprilene,renivace PubChem CID: 5388961 ChEBI: CHEBI:4785 IUPAC Name: (2S)-1-[(2S)-2-{[(2R)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}propanoyl]pyrrolidine-2-carboxylic acid; (2Z)-but-2-enedioic acid SMILES: OC(=O)\C=C/C(O)=O.CCOC(=O)[C@@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O
| PubChem CID | 5388961 |
|---|---|
| CAS | 76095-16-4 |
| Molecular Weight (g/mol) | 492.53 |
| ChEBI | CHEBI:4785 |
| MDL Number | MFCD00133304,MFCD00865774 |
| SMILES | OC(=O)\C=C/C(O)=O.CCOC(=O)[C@@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O |
| Synonym | enalapril maleate,renitec,glioten,vasotec,baripril,benalapril,crinoren,innovace,naprilene,renivace |
| IUPAC Name | (2S)-1-[(2S)-2-{[(2R)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}propanoyl]pyrrolidine-2-carboxylic acid; (2Z)-but-2-enedioic acid |
| InChI Key | OYFJQPXVCSSHAI-BMSLDGIRSA-N |
| Molecular Formula | C24H32N2O9 |
Zanamivir Hydrate 98.0+%, TCI America™
CAS: 551942-41-7 Molecular Formula: C12H22N4O8 Molecular Weight (g/mol): 350.33 MDL Number: MFCD00866966 InChI Key: OELRRAURPSTFEX-UHFFFAOYNA-N PubChem CID: 636424 IUPAC Name: 4-[(diaminomethylidene)amino]-3-acetamido-2-(1,2,3-trihydroxypropyl)-3,4-dihydro-2H-pyran-6-carboxylic acid hydrate SMILES: O.CC(=O)NC1C(C=C(OC1C(O)C(O)CO)C(O)=O)N=C(N)N
| PubChem CID | 636424 |
|---|---|
| CAS | 551942-41-7 |
| Molecular Weight (g/mol) | 350.33 |
| MDL Number | MFCD00866966 |
| SMILES | O.CC(=O)NC1C(C=C(OC1C(O)C(O)CO)C(O)=O)N=C(N)N |
| IUPAC Name | 4-[(diaminomethylidene)amino]-3-acetamido-2-(1,2,3-trihydroxypropyl)-3,4-dihydro-2H-pyran-6-carboxylic acid hydrate |
| InChI Key | OELRRAURPSTFEX-UHFFFAOYNA-N |
| Molecular Formula | C12H22N4O8 |
Nefazodone Hydrochloride 98.0+%, TCI America™
CAS: 82752-99-6 Molecular Formula: C25H33Cl2N5O2 Molecular Weight (g/mol): 506.47 MDL Number: MFCD00935760 InChI Key: DYCKFEBIOUQECE-UHFFFAOYSA-N Synonym: 2-[3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl]-5-ethyl-2,4-dihydro-4-(2-phenoxyethyl)-3H-1,2,4-triazol-3-one Hydrochloride PubChem CID: 54911 ChEBI: CHEBI:7495 IUPAC Name: hydrogen 1-{3-[4-(3-chlorophenyl)piperazin-1-yl]propyl}-3-ethyl-4-(2-phenoxyethyl)-4,5-dihydro-1H-1,2,4-triazol-5-one chloride SMILES: [H+].[Cl-].CCC1=NN(CCCN2CCN(CC2)C2=CC=CC(Cl)=C2)C(=O)N1CCOC1=CC=CC=C1
| PubChem CID | 54911 |
|---|---|
| CAS | 82752-99-6 |
| Molecular Weight (g/mol) | 506.47 |
| ChEBI | CHEBI:7495 |
| MDL Number | MFCD00935760 |
| SMILES | [H+].[Cl-].CCC1=NN(CCCN2CCN(CC2)C2=CC=CC(Cl)=C2)C(=O)N1CCOC1=CC=CC=C1 |
| Synonym | 2-[3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl]-5-ethyl-2,4-dihydro-4-(2-phenoxyethyl)-3H-1,2,4-triazol-3-one Hydrochloride |
| IUPAC Name | hydrogen 1-{3-[4-(3-chlorophenyl)piperazin-1-yl]propyl}-3-ethyl-4-(2-phenoxyethyl)-4,5-dihydro-1H-1,2,4-triazol-5-one chloride |
| InChI Key | DYCKFEBIOUQECE-UHFFFAOYSA-N |
| Molecular Formula | C25H33Cl2N5O2 |
Medisca Trichlormethiazide USP
Trichlormethiazide USP is a white or practically white, crystalline powder. It is odorless to having a slight characteristic odor.
| CAS | 133-67-5 |
|---|
| CAS | 13463-67-7 |
|---|
Medisca Riboflavin, USP (Vitamin B2) (Dietary Supplement Grade)
Riboflavin, USP (Vitamin B2) (Dietary Supplement Grade) is a yellow to orange-yellow, crystalline powder having a slight odor. It is very slightly soluble in water and in alcohol.
| CAS | 83-88-5 |
|---|
Medisca Polyethylene Glycol 400 NF (Liquid)
Polyethylene Glycol 400 NF is a clear to slightly hazy, colorless or practically colorless, viscous liquid. Has a slight characteristic odor.
| CAS | 25322-68-3 |
|---|
Medisca Magnesium Chloride, USP (Hexahydrate) (Dietary Supplement Grade)
Magnesium Chloride, USP (Hexahydrate) (Dietary Supplement Grade) colorless to white in color and variying in texture between flakes, crystals or crystalline powder.
| CAS | 7791-18-6 |
|---|
Medisca Cyproheptadine Hydrochloride USP
Cyproheptadine Hydrochloride USP is a white to slightly yellow, odorless or practically odorless, crystalline powder.
| CAS | 41354-29-4 |
|---|
Medisca Levothyroxine Sodium, USP
Levothyroxine Sodium USP is a light yellow to buff-colored, odorless, hygroscopic powder. It is stable in dry air but may assume a slight pink color upon exposure to light.
| CAS | 25416-65-3 |
|---|